Global Injectable Cytotoxic Drugs Market
Global Injectable Cytotoxic Drugs Research Report 2024: Cyclophosphamide Approval Boosts Outlook - Market to Reach $33.78 Billion by 2034 from $18.63 Billion in 2023
31 janv. 2024 09h46 HE | Research and Markets
Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Injectable Cytotoxic Drugs Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global...
Global Nasopharyngeal Cancer Market
Nasopharyngeal Cancer Market Set for Exceptional Growth: Forecast Analysis 2024-2034 with Focus on Chemotherapy and Asia-Pacific Region
29 janv. 2024 05h03 HE | Research and Markets
Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "Global Nasopharyngeal Cancer Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.In the recent...
Global Head and Neck Cancer Therapeutics Market
Head and Neck Cancer Therapeutics Market to Reach $2.3 Billion by 2027 - New Research Report Reveals
24 janv. 2024 13h26 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Global Head and Neck Cancer Therapeutics Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The latest research report...
22157.jpg
House Dust Mite Allergy Global Market Report 2024: Market will Grow from $1.9 Billion in 2023 to $3.69 Billion in 2028 - Long-term Forecast to 2033
24 janv. 2024 07h35 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "House Dust Mite Allergy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The house dust mite allergy market size...
Global Allergy Vaccine Market
Global Allergy Vaccine Market Report 2023: A $1.33 Billion Market in 2022 - Industry Size, Share, Trends, Opportunities, and Forecasts, 2018-2028F
24 janv. 2024 05h03 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Allergy Vaccine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F" report has been added to ResearchAndMarkets.com's...
22157.jpg
Global Thyroid Cancer Drugs Market Report 2024: Highlights Trends in Targeted Therapies, Featuring Profiles of Mylan Pharmaceuticals, AstraZeneca, Exelixis, Pfizer, and Bristol-Myers Squibb
23 janv. 2024 15h28 HE | Research and Markets
Dublin, Jan. 23, 2024 (GLOBE NEWSWIRE) -- The "Thyroid Cancer Drugs Global Market 2024" report has been added to ResearchAndMarkets.com's offering. The global thyroid cancer drugs market...
Myasthenia Gravis Treatment Market Will Experience Growth, Reaching US$4.1 Billion by the End of 2030, Predicts Persistence Market Research
23 janv. 2024 01h45 HE | Persistence Market Research
New York, Jan. 23, 2024 (GLOBE NEWSWIRE) -- Myasthenia Gravis Treatment Market Poised for Steady Growth, driven by Innovation and Rising Awareness The global market for myasthenia gravis (MG)...
22157.jpg
Comprehensive Analysis of the Global Chemotherapy Market, 2018-2033: Digital Health and AI are Revolutionizing Cancer Care
18 janv. 2024 06h58 HE | Research and Markets
Dublin, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The global chemotherapy market has grown rapidly in...
Immatics Final logo (R)_white_background.png
Immatics Announces Pricing of $175 Million Public Offering
17 janv. 2024 20h30 HE | https://immatics.com/
Houston, Texas and Tuebingen, Germany, January 17, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T...
Immatics Final logo (R)_white_background.png
Immatics Announces Proposed Public Offering
17 janv. 2024 16h01 HE | https://immatics.com/
Houston, Texas and Tuebingen, Germany, January 17, 2024 – Immatics N.V. (NASDAQ: IMTX, “Immatics”), a clinical-stage biopharmaceutical company active in the discovery and development of T...